Last reviewed · How we verify

NCT06954506

The Effect of Reiki on Hopelessness Level

Completed NA Last updated 1 May 2025
What this trial tests

NA trial testing Reiki Group in Oncology Patients in 32 participants. Completed in 31 March 2025.

Timeline
1 April 2023
Primary endpoint
31 March 2025
31 March 2025

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment32
Start date1 April 2023
Primary completion31 March 2025
Estimated completion31 March 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 18 to 65, any sex, with Oncology Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients. The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Reiki Group

Trials testing the same drug.

Other recruiting trials for Oncology Patients

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06954506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing